Changeflow GovPing Courts & Legal USPTO QPIDS Program Eliminates RCE Processing f...
Routine Guidance Amended Final

USPTO QPIDS Program Eliminates RCE Processing for IDS

Favicon for www.uspto.gov USPTO Patent Initiatives
Published May 10th, 2012
Detected March 22nd, 2026
Email

Summary

The USPTO has permanently implemented the Quick Path Information Disclosure Statement (QPIDS) program, which eliminates the requirement for processing a Request for Continued Examination (RCE) with an Information Disclosure Statement (IDS) filed after the issue fee payment. This change aims to streamline patent prosecution and reduce pendency.

What changed

The USPTO has made the Quick Path Information Disclosure Statement (QPIDS) program a permanent initiative, fundamentally altering the process for filing Information Disclosure Statements (IDS) after the issue fee has been paid. Previously, such an IDS would necessitate a Request for Continued Examination (RCE) for consideration. Under the QPIDS program, an RCE is no longer required for an IDS filed post-issue fee payment. If the examiner finds no new information in the IDS that warrants reopening prosecution, a corrected notice of allowability will be issued.

This change streamlines the patent prosecution process by removing a procedural hurdle for applicants. Patent applicants and their legal representatives should familiarize themselves with the QPIDS program and the associated Form SB/09 and Quick Start Guide. While no specific compliance deadline is mentioned, the program is now fully implemented, implying that any future post-issue fee IDSs should be filed under this new procedure to avoid unnecessary RCE filings and potential delays. The USPTO has also updated its FAQ regarding QPIDS, with the last update noted as January 19, 2025.

What to do next

  1. File Information Disclosure Statements (IDS) after issue fee payment under the QPIDS program.
  2. Utilize Form SB/09 for QPIDS submissions.
  3. Review the USPTO's Quick Start Guide and FAQ for QPIDS procedures.

Source document (simplified)

Quick Path Information Disclosure Statement

The Quick Path Information Disclosure Statement (QPIDS) program is part of the USPTO's on-going efforts towards compact prosecution and pendency reduction. The QPIDS program is fully implemented on a permanent basis.

In particular, the QPIDS program eliminates the requirement for processing of a request for continued examination (RCE) with an information disclosure statement (IDS) filed after payment of the issue fee in order for the IDS to be considered by the examiner. Where the examiner determines that no item of information in the IDS necessitates reopening prosecution, the USPTO will issue a corrected notice of allowability.

Press Release

USPTO to Test New Option for Information Disclosure Statements (IDS) (May 10, 2012)

Federal Register Notice

Quick Path Information Disclosure Statement (QPIDS) Pilot Program was signed on May 3, 2012, and published on May 10, 2012, at 77 Fed. Reg. 27443 [PDF].

Form

Fillable Form SB/09 (Certification and Request For Consideration of an Information Disclosure Statement Filed After Payment of the Issue Fee Under the QPIDS Program) [PDF]

Quick Start Guide

The Patent Center Quick Start Guide for the Quick Path Information Disclosure Statement (QPIDS) Program [PDF] provides information needed to rapidly understand how to file a QPIDS submission, including a brief overview of the process and screen shots that identify critical steps in the process.

Frequently Asked Questions

Frequently Asked Questions [PDF] [originally posted May 11, 2012, and last updated January 19, 2025]

Named provisions

Quick Path Information Disclosure Statement (QPIDS) Pilot Program

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
USPTO
Published
May 10th, 2012
Instrument
Guidance
Legal weight
Binding
Stage
Final
Change scope
Substantive
Document ID
77 Fed. Reg. 27443

Who this affects

Applies to
Manufacturers Drug manufacturers Medical device makers Technology companies
Industry sector
3254 Pharmaceutical Manufacturing 3345 Medical Device Manufacturing 5112 Software & Technology
Activity scope
Patent Prosecution
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Patent Prosecution Information Disclosure Statements

Get Courts & Legal alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when USPTO Patent Initiatives publishes new changes.

Free. Unsubscribe anytime.